Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

Autor: Várnai, C, Palles, C, Arnold, R, Curley, HM, Purshouse, K, Cheng, VWT, Booth, S, Campton, NA, Collins, GP, Hughes, DJ, Kulasekararaj, AG, Lee, AJX, Olsson-Brown, AC, Sharma-Oates, A, Van Hemelrijck, M, Lee, LYW, Kerr, R, Middleton, G, Cazier, J-B, UKCCMP Team

Importance Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence of the association of recent cancer treatment and cancer type with COVID-19 mortality. Objective To evaluate whether systemic anticancer tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3ff0a2c1612604ec79d5d24fc67d34d0
https://eprints.whiterose.ac.uk/184087/1/vrnai_2022_oi_220011_1644548912.0317.pdf

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.

Autor: Booth S; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, UK., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Varnai C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Department of Oncology, Oxford University, Oxford, UK., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK., Cook G; NIHR (Leeds) MIC, Leeds, St James's Teaching Hospital, University of Leeds, Leeds, UK., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK., Aries J; Barts Health NHS Trust, London, UK., Innes A; Imperial College Healthcare NHS Trust, London, UK., Cook LB; Imperial College Healthcare NHS Trust, London, UK., Tomkins O; Leswisham and Greenwich NHS Trust, London, UK., Oram HS; Leswisham and Greenwich NHS Trust, London, UK., Tilby M; Queen Elizabeth Hospital, Birmingham, UK., Kulasekararaj A; Department of Haematology, King's College Hospital, London, UK., Wrench D; Guys and St Thomas' NHS Foundation Trust, London, UK., Dolly S; Guys and St Thomas' NHS Foundation Trust, London, UK., Newsom-Davies T; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Pettengell R; St Georges University Hospitals NHS Foundation Trust, London, UK., Gault A; NCCC Northern Centre for Cancer Care, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK., Moody S; NCCC Northern Centre for Cancer Care, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK., Mittal S; Northampton General Hospital NHS Trust, Northampton, UK., Altohami M; Northampton General Hospital NHS Trust, Northampton, UK., Tillet T; Royal United Hospitals Bath, Bath, UK., Illingworth J; Barking, Havering and Redbridge University Hospitals NHS Trust, Essex, UK., Mukherjee L; Beatson West of Scotland Cancer Centre, Glasgow, UK., Apperly J; Imperial College Healthcare NHS Trust, London, UK., Ashcroft J; NIHR (Leeds) MIC, Leeds, St James's Teaching Hospital, University of Leeds, Leeds, UK.; Mid Yorkshire Hospitals NHS Trust, Wakefield, UK., Rabin N; University College London Hospitals, London, UK., Carmichael J; NIHR (Leeds) MIC, Leeds, St James's Teaching Hospital, University of Leeds, Leeds, UK., Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Kerr R; Department of Oncology, Oxford University, Oxford, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, UK., Collins GP; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, UK., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (4), pp. 892-901. Date of Electronic Publication: 2021 Nov 10.

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.

Autor: Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Oncology, University of Oxford, Oxford, UK; University Hospitals Birmingham, Birmingham, UK., Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Briggs SEW; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Bisht V; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Booth S; Department of Haematology, University of Oxford, Oxford, UK., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK., Cheng VWT; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Collins G; Department of Haematology, University of Oxford, Oxford, UK., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Earwaker P; University Hospitals Birmingham, Birmingham, UK., Fittall MW; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Gennatas S; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Goel A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Hartley S; Centre for Computational Biology, University of Birmingham, Birmingham, UK; Advanced Research Computing, University of Birmingham, Birmingham, UK., Hughes DJ; Department of Cancer Imaging, King's College London, London, UK., Kerr D; Nuffield Division of Clinical and Laboratory Services, University of Oxford, Oxford, UK., Lee AJX; UCL Cancer Institute, University College London, London, UK., Lee RJ; The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Lee SM; University College London, London, UK., Mckenzie H; University Hospital Southampton, UK., Middleton CP; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Murugaesu N; St George's University Hospitals NHS Foundation Trust, London, UK., Newsom-Davis T; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Olsson-Brown AC; The Clatterbridge Cancer Centre, Birkenhead, UK., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Powles T; Bart's Cancer Institute, London, UK., Protheroe EA; University of Birmingham Medical School, University of Birmingham, Birmingham, UK., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK., Sharma-Oates A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Sivakumar S; Department of Oncology, University of Oxford, Oxford, UK., Smith AJ; Consultancy Support, Oxford, UK., Topping O; University Hospitals Birmingham, Birmingham, UK., Turnbull CD; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Várnai C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Briggs ADM; Warwick Medical School, University of Warwick, Coventry, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK. Electronic address: g.middleton@bham.ac.uk., Kerr R; Department of Oncology, University of Oxford, Oxford, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2020 Oct; Vol. 21 (10), pp. 1309-1316. Date of Electronic Publication: 2020 Aug 24.